Regis Healthcare Shares Plunge 27%: What Just Happened?

Regis Healthcare shares (ASX:REG) suffered one of the worst single-day sell-offs in its recent history, closing 26.99% lower at A$4.30. It could have been far worse for holders, with the session seeing the REG share price touch A$3.85 intraday, its lowest level in more than two years, before rebounding roughly 10% into the close.

With heavy volume of 8.23million shares changing hands on the day, some 8.64x the average, what actually drove the selling pressure that saw shares make a multi year low?

Bears were set in motion as the federal government’s latest aged care funding decision confirmed that reimbursement growth will once again lag the sector’s rapidly rising wage and operating costs. The announcement has reignited concerns about a structural margin squeeze for residential aged care providers and pushed the stock’s policy-risk discount sharply higher.

The decline extends an already painful stretch for shareholders, with the stock now down 38.13% year to date. The severity of the move echoes a near-identical episode in September 2025, when markets dumped the stock by roughly 26-27% in a single session after concluding that a headline 4.7% funding increase would translate into only about a 2.6% effective uplift once resident classification changes were applied. That precedent appears to have primed markets to assume the worst when Canberra sets aged care funding, helping explain the speed and depth of the latest reaction.

The Funding Decision

From 1 October 2026, the Australian National Aged Care Classification (AN-ACC) starting price for residential aged care will rise 2.55%, from A$295.64 to A$303.19 per resident per day. The hoteling supplement, which covers everyday living services, will remain frozen at A$22.15 per resident per day, while care-minute requirements and the existing fixed and variable funding categories stay unchanged.

The problem for Regis and its peers is the gap between that 2.55% uplift and the sector’s actual cost trajectory. Award-based aged care workers are set to receive a 4.75% wage increase from 1 July 2026, with nurses in line for additional rises of between 1.5% and 4.4% from 1 August 2026 under the Fair Work Commission’s Work Value Case. Consumer price inflation, meanwhile, is running at roughly 3.5-3.8%. In other words, every major cost line is growing faster than the revenue the government provides to cover it.

The Department of Health has noted the changes will lift average funding from an estimated A$317 to about A$325 per resident per day, adding approximately A$1 billion to the aged care budget. A separate review of the hoteling supplement by the Independent Health and Aged Care Pricing Authority is under way, but updated advice is not expected until late 2027, leaving a key revenue line in limbo for years.

Regis, which cares for around 10,000 residents and clients with a 13,000-strong workforce, said it will continue advocating for adequate sector funding while pressing ahead with its mitigation strategy. That includes raising room prices, expanding its Higher Everyday Living Fee (HELF) premium services, and pursuing revenue optimisation and operational efficiency programs.

What Next?

Even before this decision, the company’s EBITDA margin had slipped from around 10.8% to 10.2% as mandated wage increases outpaced funding indexation, and sector data showed staff costs surging roughly 22% in a recent half-year period while funding growth remained capped. Two funding-related share price crashes in as many years have entrenched the view that earnings are hostage to decisions made in Canberra, justifying a higher risk premium and lower valuation multiples.

The bear case from here is straightforward: if funding indexation continues to trail wage awards and CPI, margins compress mechanically, capital available for new beds and refurbishments shrinks, and the growth pipeline stalls. The drawn-out hoteling review only compounds multi-year policy uncertainty.

The bull case rests on factors the sell-off may be overlooking. Demographic tailwinds remain powerful, with an ageing population underpinning long-term demand and occupancy. Regis has demonstrated genuine pricing power through room price increases and strong refundable accommodation deposit inflows, and its scale positions it better than smaller rivals to absorb compliance costs and capture efficiencies, particularly if weaker operators exit the sector.

For now, markets are pricing Regis as a business whose economics are dictated more by government funding formulas than by its own execution, and the burden of proof sits squarely on management to show that pricing, premium services and efficiency gains can stabilise margins. Until either the numbers or Canberra’s stance demonstrably improve, the shares are likely to carry a heavy policy-risk discount, though for patient holders, the combination of structural demand, pricing levers and a potential funding rethink offers a credible, if distant, path to recovery.